• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Abatacept for graft versus host disease prophylaxis in patients 60 years and older receiving mismatched unrelated donor transplantation for hematologic malignancies.

作者信息

Raghunandan Sharmila, Qayed Muna, Watkins Ben K, Graiser Michael, Gorfinkel Lev, Westbrook Adrianna, Gillespie Scott, Bratrude Brandi, Petrovic Aleksandra, Suessmuth Yvonne, Horan John, Kean Leslie S, Langston Amelia A

机构信息

Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA.

Emory University, Atlanta, GA, USA.

出版信息

Bone Marrow Transplant. 2023 Nov;58(11):1264-1266. doi: 10.1038/s41409-023-02043-y. Epub 2023 Aug 14.

DOI:10.1038/s41409-023-02043-y
PMID:37580397
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10622309/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1dc/10622309/2e23a1112bfc/41409_2023_2043_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1dc/10622309/2e23a1112bfc/41409_2023_2043_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1dc/10622309/2e23a1112bfc/41409_2023_2043_Fig1_HTML.jpg

相似文献

1
Abatacept for graft versus host disease prophylaxis in patients 60 years and older receiving mismatched unrelated donor transplantation for hematologic malignancies.阿巴西普用于预防60岁及以上接受错配无关供体移植治疗血液系统恶性肿瘤患者的移植物抗宿主病。
Bone Marrow Transplant. 2023 Nov;58(11):1264-1266. doi: 10.1038/s41409-023-02043-y. Epub 2023 Aug 14.
2
Abatacept for the prevention of graft versus host disease in pediatric patients receiving 7/8 HLA-mismatched unrelated transplant for hematologic malignancies: a real-world analysis.阿巴西普预防接受7/8 HLA错配非亲缘造血恶性肿瘤移植的儿科患者移植物抗宿主病：一项真实世界分析
Bone Marrow Transplant. 2023 Nov;58(11):1260-1263. doi: 10.1038/s41409-023-02034-z. Epub 2023 Aug 14.
3
Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation.一项双臂2期临床试验的结果，该试验使用移植后环磷酰胺预防单倍体相合供者和错配无关供者造血干细胞移植中的移植物抗宿主病。
Cancer. 2016 Nov 15;122(21):3316-3326. doi: 10.1002/cncr.30180. Epub 2016 Jul 12.
4
The Role of Low-dose Anti-thymocyte Globulin as Standard Prophylaxis in Mismatched and Matched Unrelated Hematopoietic Peripheral Stem Cell Transplantation for Hematologic Malignancies.低剂量抗胸腺细胞球蛋白在血液系统恶性肿瘤不匹配及匹配的非亲缘造血外周血干细胞移植中作为标准预防措施的作用
Clin Lymphoma Myeloma Leuk. 2017 Oct;17(10):658-666. doi: 10.1016/j.clml.2017.06.008. Epub 2017 Jun 29.
5
Abatacept for acute graft-versus-host disease prophylaxis after unrelated donor hematopoietic cell transplantation.阿巴西普用于异基因造血细胞移植后急性移植物抗宿主病的预防。
Blood. 2024 Oct 24;144(17):1834-1845. doi: 10.1182/blood.2023023660.
6
Comparison of graft-versus-host disease-free, relapse-free survival of transplantation using matched sibling donor, matched unrelated donor or unrelated cord blood after myeloablative conditioning for adult patients with hematological malignancies.对于患有血液系统恶性肿瘤的成年患者，在进行清髓性预处理后，使用匹配的同胞供者、匹配的无关供者或无关脐血进行移植的无移植物抗宿主病、无复发生存率的比较。
Leuk Lymphoma. 2016 Sep;57(9):2126-32. doi: 10.3109/10428194.2015.1122784. Epub 2016 Jan 14.
7
How I prevent GVHD in high-risk patients: posttransplant cyclophosphamide and beyond.我如何预防高危患者的移植物抗宿主病：移植后环磷酰胺及其他方法。
Blood. 2023 Jan 5;141(1):49-59. doi: 10.1182/blood.2021015129.
8
Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation.用于预防移植物抗宿主病的阿巴西普可通过消除无关供体干细胞移植中配型不相合的影响来减少种族差异。
Blood Adv. 2022 Feb 8;6(3):746-749. doi: 10.1182/bloodadvances.2021005208.
9
Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial.在接受无关供体移植的血液系统恶性肿瘤患者中，在标准移植物抗宿主病预防方案基础上加用抗胸腺细胞球蛋白与单纯标准治疗的对比：一项随机、开放标签、多中心3期试验的最终分析。
Lancet Haematol. 2020 Feb;7(2):e100-e111. doi: 10.1016/S2352-3026(19)30220-0. Epub 2020 Jan 17.
10
A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A Phase II Trial.基于硼替佐米的方案在清髓性HLA配型不合及无关供者移植中提供了有前景的生存及移植物抗宿主病预防效果：一项II期试验
Biol Blood Marrow Transplant. 2015 Nov;21(11):1907-13. doi: 10.1016/j.bbmt.2015.05.027. Epub 2015 Jun 6.

引用本文的文献

1
Allogeneic Transplantation for Older Adults.老年人的异体移植
Adv Exp Med Biol. 2025;1475:9-40. doi: 10.1007/978-3-031-84988-6_2.
2
Graft-Versus-Host Disease Mouse Models: A Clinical-Translational Perspective.移植物抗宿主病小鼠模型：临床转化视角
Methods Mol Biol. 2025;2907:1-56. doi: 10.1007/978-1-0716-4430-0_1.
3
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in adults over 70 years old.70岁以上成人急性髓系白血病的异基因造血细胞移植

本文引用的文献

1
Allogeneic hematopoietic cell transplantation for older patients.异基因造血细胞移植治疗老年患者。
Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):254-263. doi: 10.1182/hematology.2021000257.
2
How old is too old for a transplant?对于移植来说，年龄多大算太大了？
Best Pract Res Clin Haematol. 2021 Mar;34(1):101243. doi: 10.1016/j.beha.2021.101243. Epub 2021 Jan 12.
3
Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD.阿巴西普阻断共刺激用于预防急性移植物抗宿主病的 II 期临床试验。
Blood. 2025 Jun 12;145(24):2847-2856. doi: 10.1182/blood.2024024247.
J Clin Oncol. 2021 Jun 10;39(17):1865-1877. doi: 10.1200/JCO.20.01086. Epub 2021 Jan 15.
4
Risk factors for acute GVHD and survival after hematopoietic cell transplantation.造血细胞移植后急性移植物抗宿主病的危险因素和生存情况。
Blood. 2012 Jan 5;119(1):296-307. doi: 10.1182/blood-2011-06-364265. Epub 2011 Oct 18.
5
HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation.HLA-C 抗原错配与无关供体外周血造血干细胞移植后不良结局相关。
Biol Blood Marrow Transplant. 2011 Jun;17(6):885-92. doi: 10.1016/j.bbmt.2010.09.012. Epub 2010 Sep 24.
6
Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors.采用匹配同胞供者、非亲缘相关供者或匹配无关供者进行小儿骨髓移植治疗白血病和骨髓增生异常综合征的结果。
Blood. 2010 Nov 11;116(19):4007-15. doi: 10.1182/blood-2010-01-261958. Epub 2010 Jul 29.
7
High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.高分辨率的供受者人类白细胞抗原（HLA）配型有助于无关供者骨髓移植的成功。
Blood. 2007 Dec 15;110(13):4576-83. doi: 10.1182/blood-2007-06-097386. Epub 2007 Sep 4.
8
Abatacept.阿巴西普
Nat Rev Drug Discov. 2006 Mar;5(3):185-6. doi: 10.1038/nrd1989.